Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
WD repeat domain 87B, pseudogene (WDR87BP) is a human pseudogene—a non-protein-coding DNA sequence similar to a functional gene (in this case, likely WD repeat domain 87B) but typically rendered non-functional by mutations or absence of regulatory elements[2][3][4]. Pseudogenes can play regulatory roles at the RNA level (such as generating noncoding RNAs or acting as miRNA decoys), participate in DNA-level sequence exchange with their parental genes, and sometimes impact gene networks or disease susceptibility, but WDR87BP itself has no evidence of protein product, drug targeting, or validated biological function or disease association[2][3][4]. It should not be considered a therapeutic target in the standard sense; instead, it fits the classification of genomic “other”/noncoding locus. Given its status as a pseudogene, important functional, biomarker, or safety information is absent, and there is no evidence it serves as a receptor, enzyme, transporter, or similar relevant target class[2][3][4]. There is no indication of direct interaction with any drugs or role in patient selection or safety monitoring; thus most target-based categories are not applicable.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WD repeat domain 87B, pseudogene (WDR87BP).